Delivery Order SPE2DB24D2205-SPE2DB25FEHLV
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Lyrica 100 mg capsules in a 90-count quantity with a ceiling value of $1,183.60. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is scheduled for completion by September 11, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,761.42 to AmerisourceBergen Drug Corp for the supply of Lyrica 100 mg capsules (90-count units). This competitively awarded, firm fixed-price delivery order was issued on September 10, 2025, with an ultimate completion date of September 11, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competed among...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 9, 2025, for the supply of Lyrica 100 mg capsules (90-count units) valued at $2,530.67. This firm fixed-price delivery order, which is set to be completed by September 10, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was awarded competitively with no set-aside designation, and the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Lyrica 100 mg capsules (90 count) with a contract value of $4,272.77. This is a firm fixed price delivery order with an ultimate completion date of August 19, 2025, and represents a non-competitive set-aside award. AmerisourceBergen will perform this work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- This delivery order, awarded on September 8, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, covers the supply of Lyrica 100 mg capsules (90-count units) with a ceiling value of $1,652.76. The contract utilizes a firm fixed-price structure with an ultimate completion date of September 9, 2025, and represents a non-set-aside competitive award. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,851.66 to AmerisourceBergen Drug Corp for the supply of Lyrica 200 mg capsules (90-count units) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a $7,159.80 delivery order to AmerisourceBergen Drug Corp for the supply of Lyrica 100 mg capsules (90-count units) under a firm fixed-price contract. The award was made on July 21, 2025, with an ultimate completion date of July 22, 2025, and represents a non-set-aside competitive award. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lyrica 100 mg capsules (unit dose, 100 count) on August 20, 2025, with an ultimate completion date of August 21, 2025. This is a firm fixed price delivery order with a ceiling value of $1,128.56 and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA. The award was made through open competition with no set-aside designation. AmerisourceBergen, headquartered in...
- The Defense Logistics Agency awarded a $3,551.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lyrica 200 mg capsules (90-count units) on August 22, 2025, with an ultimate completion date of August 25, 2025. This non-competitive delivery order represents a routine pharmaceutical procurement under the company's existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lyrica 100 mg capsules (90-count units) under a firm fixed price contract. The delivery order, valued at $3,550.74, was issued on August 28, 2025, with an ultimate completion date of August 29, 2025. This non-set-aside award represents a direct purchase from the vendor's existing federal contract vehicle, with performance to take place at AmerisourceBergen's corporate headquarters in...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEHLVDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,580.34 to AmerisourceBergen Drug Corp for the supply of Lyrica 100 mg capsules (90-count units). This firm fixed price, competitively awarded contract was issued on September 11, 2025, with an ultimate completion date of September 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified pharmaceutical distributors. This delivery order represents a single transaction under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical supply vehicle running through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a broad portfolio of medications and medical supplies to support military healthcare systems and other government agencies. The Lyrica delivery supports the DLA Medical Supply Chain's mission to ensure consistent pharmaceutical availability across defense health operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 9/11/25 |